GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » PB Ratio

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) PB Ratio : 8.24 (As of May. 17, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-17), Laboratorios Farmaceuticos Rovi's share price is €85.75. Laboratorios Farmaceuticos Rovi's Book Value per Share for the quarter that ended in Dec. 2023 was €10.41. Hence, Laboratorios Farmaceuticos Rovi's PB Ratio of today is 8.24.

Warning Sign:

Laboratorios Farmaceuticos Rovi SA stock PB Ratio (=8.24) is close to 10-year high of 9.02

The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's PB Ratio or its related term are showing as below:

XMAD:ROVI' s PB Ratio Range Over the Past 10 Years
Min: 2.48   Med: 4.17   Max: 9.02
Current: 8.24

During the past 13 years, Laboratorios Farmaceuticos Rovi's highest PB Ratio was 9.02. The lowest was 2.48. And the median was 4.17.

XMAD:ROVI's PB Ratio is ranked worse than
86.34% of 1318 companies
in the Biotechnology industry
Industry Median: 2.555 vs XMAD:ROVI: 8.24

During the past 12 months, Laboratorios Farmaceuticos Rovi's average Book Value Per Share Growth Rate was 4.80% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 15.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 16.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 15.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Laboratorios Farmaceuticos Rovi was 50.20% per year. The lowest was 6.80% per year. And the median was 15.80% per year.

Back to Basics: PB Ratio


Laboratorios Farmaceuticos Rovi PB Ratio Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi PB Ratio Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.19 5.62 8.59 3.63 5.78

Laboratorios Farmaceuticos Rovi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.55 4.37 4.94 5.78 -

Competitive Comparison of Laboratorios Farmaceuticos Rovi's PB Ratio

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's PB Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's PB Ratio falls into.



Laboratorios Farmaceuticos Rovi PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Laboratorios Farmaceuticos Rovi's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=85.75/10.409
=8.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Laboratorios Farmaceuticos Rovi  (XMAD:ROVI) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Laboratorios Farmaceuticos Rovi PB Ratio Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Headlines

From GuruFocus

Rovi Corp. (ROVI) President and CEO Alfred J Amoroso sells 33,957 Shares

By GuruFocus Research GuruFocus Editor 02-03-2011

Rovi Corp. (ROVI) EVP & CFO James Budge sells 44,145 Shares

By GuruFocus Research GuruFocus Editor 03-04-2011

Rovi Corp. (ROVI) President and CEO Alfred J Amoroso sells 33,957 Shares

By GuruFocus Research GuruFocus Editor 03-19-2011

Rovi Corp. (ROVI) President and CEO Alfred J Amoroso sells 529,463 Shares

By GuruFocus Research GuruFocus Editor 03-19-2011

TiVo Corporation to Announce First Quarter 2020 Results

By Business Wire Business Wire 04-23-2020

Rovi Corp. (ROVI) President and CEO Alfred J Amoroso sells 96,461 Shares

By GuruFocus Research GuruFocus Editor 03-04-2011